{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:56:17Z","timestamp":1788432977100,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170197"],"award-info":[{"award-number":["82170197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022D015"],"award-info":[{"award-number":["2022D015"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024R1036"],"award-info":[{"award-number":["2024R1036"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20220530143403007"],"award-info":[{"award-number":["JCYJ20220530143403007"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010076"],"award-info":[{"award-number":["2024A1515010076"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["254000510004"],"award-info":[{"award-number":["254000510004"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004609","name":"Foundation of Henan Educational Committee","doi-asserted-by":"publisher","award":["24A320060"],"award-info":[{"award-number":["24A320060"]}],"id":[{"id":"10.13039\/501100004609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,10,7]]},"DOI":"10.1038\/s41388-025-03513-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T04:28:38Z","timestamp":1753676918000},"page":"3553-3567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy"],"prefix":"10.1038","volume":"44","author":[{"given":"Zou","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-0716","authenticated-orcid":false,"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-5136","authenticated-orcid":false,"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"3513_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"3513_CR2","doi-asserted-by":"crossref","unstructured":"Liu H, He J, Koh SP, Zhong Y, Liu Z, Wang Z et al. Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci Transl Med. 2019;11:eaau9087.","DOI":"10.1126\/scitranslmed.aau9087"},{"key":"3513_CR3","doi-asserted-by":"publisher","first-page":"353ra113","DOI":"10.1126\/scitranslmed.aad8949","volume":"8","author":"H Liu","year":"2016","unstructured":"Liu H, Liu Z, Du J, He J, Lin P, Amini B et al. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma. Sci Transl Med. 2016;8:353ra113.","journal-title":"Sci Transl Med"},{"key":"3513_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327:464\u201377.","journal-title":"JAMA"},{"key":"3513_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33944-z","volume":"13","author":"R Boiarsky","year":"2022","unstructured":"Boiarsky R, Haradhvala NJ, Alberge JB, Sklavenitis-Pistofidis R, Mouhieddine TH, Zavidij O et al. Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis. Nat Commun. 2022;13:7040.","journal-title":"Nat Commun"},{"key":"3513_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003;349:2483\u201394.","journal-title":"N Engl J Med"},{"key":"3513_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrc746","volume":"2","author":"WM Kuehl","year":"2002","unstructured":"Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2:175\u201387.","journal-title":"Nat Rev Cancer"},{"key":"3513_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1182\/blood.V72.2.796.796","volume":"72","author":"H Tsuchiya","year":"1988","unstructured":"Tsuchiya H, Epstein J, Selvanayagam P, Dedman JR, Gallick G, Alexanian R et al. Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma. Blood. 1988;72:796\u2013800.","journal-title":"Blood"},{"key":"3513_CR9","first-page":"34","volume":"37","author":"PL Zhang","year":"2007","unstructured":"Zhang PL, Quiery AT Jr., Blasick TM, Brown RE. Morphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment. Ann Clin Lab Sci. 2007;37:34\u20138.","journal-title":"Ann Clin Lab Sci"},{"key":"3513_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","volume":"2","author":"CJ Sherr","year":"2002","unstructured":"Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2:103\u201312.","journal-title":"Cancer Cell"},{"key":"3513_CR11","doi-asserted-by":"crossref","unstructured":"Roy P, Sarkar UA, Basak S. The NF-kappaB activating pathways in multiple myeloma. Biomedicines. 2018;6:59.","DOI":"10.3390\/biomedicines6020059"},{"key":"3513_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-018-0615-3","volume":"11","author":"I Spaan","year":"2018","unstructured":"Spaan I, Raymakers RA, van de Stolpe A, Peperzak V. Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential. J Hematol Oncol. 2018;11:67.","journal-title":"J Hematol Oncol"},{"key":"3513_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminoncol.2017.10.013","volume":"44","author":"F Alessandrini","year":"2017","unstructured":"Alessandrini F, Pezze L, Ciribilli Y. LAMPs: shedding light on cancer biology. Semin Oncol. 2017;44:239\u201353.","journal-title":"Semin Oncol"},{"key":"3513_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00401-022-02457-w","volume":"144","author":"Y Deng","year":"2022","unstructured":"Deng Y, Bi M, Delerue F, Forrest SL, Chan G, van der Hoven J et al. Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer\u2019s disease. Acta Neuropathol. 2022;144:637\u201350.","journal-title":"Acta Neuropathol"},{"key":"3513_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00695-1","volume":"8","author":"A Combes","year":"2017","unstructured":"Combes A, Camosseto V, N\u2019Guessan P, Arguello RJ, Mussard J, Caux C et al. BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells. Nat Commun. 2017;8:913.","journal-title":"Nat Commun"},{"key":"3513_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10120-022-01284-y","volume":"25","author":"S Umeda","year":"2022","unstructured":"Umeda S, Kanda M, Shimizu D, Nakamura S, Sawaki K, Inokawa Y et al. Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells. Gastric Cancer. 2022;25:558\u201372.","journal-title":"Gastric Cancer"},{"key":"3513_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0262-0","volume":"9","author":"HC Beird","year":"2019","unstructured":"Beird HC, Khan M, Wang F, Alfayez M, Cai T, Zhao L et al. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood Cancer J. 2019;9:99.","journal-title":"Blood Cancer J"},{"key":"3513_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3324\/haematol.2020.257451","volume":"107","author":"G Gracia-Maldonado","year":"2022","unstructured":"Gracia-Maldonado G, Clark J, Burwinkel M, Greenslade B, Wunderlich M, Salomonis N et al. LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia. Haematologica. 2022;107:803\u201315.","journal-title":"Haematologica"},{"key":"3513_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2023.1611083","volume":"29","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ma T. LAMP5 may promote MM progression by activating p38. Pathol Oncol Res. 2023;29:1611083.","journal-title":"Pathol Oncol Res"},{"key":"3513_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","volume":"35","author":"J Charan","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research?. Indian J Psychol Med. 2013;35:121\u20136.","journal-title":"Indian J Psychol Med"},{"key":"3513_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W et al. IRF4 addiction in multiple myeloma. Nature. 2008;454:226\u201331.","journal-title":"Nature"},{"key":"3513_CR22","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/nar\/gkaa1287","volume":"49","author":"S Sundararaj","year":"2021","unstructured":"Sundararaj S, Seneviratne S, Williams SJ, Enders A, Casarotto MG. Structural determinants of the IRF4\/DNA homodimeric complex. Nucleic Acids Res. 2021;49:2255\u201365.","journal-title":"Nucleic Acids Res"},{"key":"3513_CR23","doi-asserted-by":"crossref","unstructured":"Li X, Zheng J, Su J, Wang L, Luan L, Wang T et al. Myotubularin 2 interacts with SEC23A and negatively regulates autophagy at ER exit sites in Arabidopsis. Autophagy. 2024;21:141\u201359.","DOI":"10.1080\/15548627.2024.2394302"},{"key":"3513_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.celrep.2018.03.078","volume":"23","author":"P Zhang","year":"2018","unstructured":"Zhang P, Xiao Z, Wang S, Zhang M, Wei Y, Hang Q et al. ZRANB1 is an EZH2 deubiquitinase and a potential therapeutic target in breast cancer. Cell Rep. 2018;23:823\u201337.","journal-title":"Cell Rep"},{"key":"3513_CR25","doi-asserted-by":"crossref","unstructured":"Cheng Z, Gan W, Xiang Q, Zhao K, Gao H, Chen Y et al. Impaired degradation of PLCG1 by chaperone-mediated autophagy promotes cellular senescence and intervertebral disc degeneration. Autophagy. 2024;21:352\u201373.","DOI":"10.1080\/15548627.2024.2395797"},{"key":"3513_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ncb2788","volume":"15","author":"P Boya","year":"2013","unstructured":"Boya P, Reggiori F, Codogno P. Emerging regulation and functions of autophagy. Nat Cell Biol. 2013;15:713\u201320.","journal-title":"Nat Cell Biol"},{"key":"3513_CR27","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/bjc.2015.165","volume":"112","author":"AT Alshareeda","year":"2015","unstructured":"Alshareeda AT, Negm OH, Green AR, Nolan CC, Tighe P, Albarakati N et al. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. Br J Cancer. 2015;112:1929\u201337.","journal-title":"Br J Cancer"},{"key":"3513_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hon.3016","volume":"40","author":"A Agnarelli","year":"2022","unstructured":"Agnarelli A, Mitchell S, Caalim G, Wood CD, Milton-Harris L, Chevassut T et al. Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma. Hematol Oncol. 2022;40:417\u201329.","journal-title":"Hematol Oncol"},{"key":"3513_CR29","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.7150\/thno.75431","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen H, Liu W, Yan H, Zhang Y, Cheung AHK et al. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target. Theranostics. 2022;12:6509\u201326.","journal-title":"Theranostics"},{"key":"3513_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.leukres.2018.07.025","volume":"72","author":"A Agnarelli","year":"2018","unstructured":"Agnarelli A, Chevassut T, Mancini EJ. IRF4 in multiple myeloma-Biology, disease and therapeutic target. Leuk Res. 2018;72:52\u20138.","journal-title":"Leuk Res"},{"key":"3513_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science. 2014;343:301\u20135.","journal-title":"Science"},{"key":"3513_CR32","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/leu.2015.169","volume":"29","author":"Z Xie","year":"2015","unstructured":"Xie Z, Bi C, Chooi JY, Chan ZL, Mustafa N, Chng WJ. MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib. Leukemia. 2015;29:2347\u201354.","journal-title":"Leukemia"},{"key":"3513_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammaren HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:201.","journal-title":"Nat Commun"},{"key":"3513_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","volume":"33","author":"Z Li","year":"2021","unstructured":"Li Z, Liu H, He J, Wang Z, Yin Z, You G et al. Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma. Cell Metab. 2021;33:78\u201393 e77.","journal-title":"Cell Metab"},{"key":"3513_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2130-z","volume":"10","author":"F Wang","year":"2019","unstructured":"Wang F, Sun F, Luo J, Yue T, Chen L, Zhou H et al. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization. Cell Death Dis. 2019;10:892.","journal-title":"Cell Death Dis"},{"key":"3513_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101905","volume":"298","author":"BS Rutledge","year":"2022","unstructured":"Rutledge BS, Choy WY, Duennwald ML. Folding or holding?-Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease. J Biol Chem. 2022;298:101905.","journal-title":"J Biol Chem"},{"key":"3513_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2020.103923","volume":"116","author":"W Li","year":"2021","unstructured":"Li W, Ling L, Wang Z, Liang Y, Huang W, Nie P et al. Functional domains and amino acid residues of Japanese eel IRF1, AjIRF1, regulate its nuclear import and IFN\/Mx promoter activation. Dev Comp Immunol. 2021;116:103923.","journal-title":"Dev Comp Immunol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03513-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:02:10Z","timestamp":1757973730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03513-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":37,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025,10,7]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03513-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}